Clinical trial Recruiting at 1 site Interventional Ages 21 to 70

Telehealth program for weight management and related health issues

Official title: OneSTOP (One-Stop Telehealth Obesity Program): the Use of Telecare and Digital Platforms for Multidisciplinary Management of Weight Management and Related Comorbidities

Run by Changi General Hospital · NCT06890169 · Data updated 2026-11-12

This study is testing a new telehealth program for weight management to see if it helps obese adults with type 2 diabetes and liver issues lose weight and improve their health better than traditional in-person programs.

Quick facts

Study typeInterventional
Ages21 Years to 70 Years
SexAll
Enrollment120 (estimated)
SponsorChangi General Hospital
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedMay 1, 2025
Main results expectedFebruary 28, 2027
Study endsAugust 31, 2027
Registry record updatedMarch 21, 2025
Trial IDNCT06890169 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21-70 with a BMI greater than 27.5 kg/m2 and suboptimal control of type 2 diabetes or MASLD.

Probably not a fit

Patients with a life expectancy of less than 6 months or those unable to comply with written instructions in English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of the OneSTOP Telehealth Obesity Program, which combines teleconsultations and the EMPOWER app, in inducing significant weight loss and metabolic improvements in obese adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). Participants will be randomly assigned to either the OneSTOP program or a conventional face-to-face weight management program over a 26-week period. The study will compare the outcomes of both approaches in terms of weight loss, patient convenience, and adherence to dietary and exercise recommendations.

Why it matters

Potential benefit: If successful, this program could provide a more accessible and effective method for managing obesity and related metabolic conditions.

How similar studies have gone: Other studies have shown promising results with telehealth approaches for weight management, indicating potential for success in this novel intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 21-70
* Body mass index \> 27.5 kg/m2
* Waist circumference \> 90 cm in men or 80 cm in women
* Suboptimal control of type 2 diabetes (HbA1c \> 6.5%) AND/OR MASLD (as defined on radiological or histological evidence of hepatic steatosis in the absence of other chronic liver disease)

Exclusion Criteria:

* Men who drink \> 21 units/week and women who drink \> 14 units/week of alcohol
* Participants previously on weight-lowering medications (however if they are keen to participate, there will be a minimum wash-out period of 3 months before participation)
* Illness with life expectancy of less than 6 months
* Inability to comply with written instructions in English

Where it's running

  • Changi General Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.